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Abstract
The aim of the study was to compare the diagnostic efficacy of the visual assessment of diffusion-weighted imaging (DWI) 
and dynamic contrast-enhanced (DCE) sequences compared to the STIR sequence in the diagnostics of active sacroiliitis in 
the course of axial spondyloarthritis (axSpA). The study group consisted of 49 patients who had undergone multiparametric 
magnetic resonance imaging of the sacroiliac joints (SIJs) due to clinical suspicion of axSpA. Two independent observers 
retrospectively assessed four quadrants of the SIJs for the presence of subchondral bone marrow oedema/osteitis with the 
use of modified SPARCC score in sequences: STIR, DWI (with ADC map) and DCE. Diagnostic efficiency parameters 
were calculated for DWI and DCE sequence separately, using STIR sequence as a reference. Inter-observer agreement was 
evaluated with the use of κ coefficient. Patients’ clinical symptoms were analysed to identify the group fulfilling the imag-
ing arm of the ASAS criteria for axSpA. Overall, 46.9% (n = 23) of patients fulfilled the imaging arm of ASAS criteria for 
axial spondyloarthritis. DWI with ADC map: accuracy 95.6%, sensitivity 99.4%, specificity 54.0%. DCE sequence: accuracy 
96.8%, sensitivity 98.4%, specificity 79.5%. The highest level of inter-observer agreement was achieved for STIR sequence 
(κ = 0.888), slightly lower for DCE sequence (κ = 0.773) and the lowest for DWI with ADC (κ = 0.674). Visual assessment of 
the DWI and DCE sequences has high accuracy and sensitivity of bone marrow oedema/osteitis detection, but the specificity 
and inter-observer agreement are poor, especially for the DWI sequence with ADC maps.
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Introduction
The heterogeneous group of rheumatic diseases, known 
under the name of spondyloarthritis (SpA), has been divided 
into two categories: axial (axSpA) and peripheral spondy-
loarthritis (pSpA) [1]. In the first type, the axial skeleton is 
predominantly involved, while in the second, only peripheral 
manifestations of the disease are observed.
In 2009, magnetic resonance imaging (MRI) of sacroiliac 
joints (SIJs) was included into the Assessment of Spondy-
loArthritis international Society (ASAS) SpA diagnostic 
criteria. It resulted in the introduction of axSpA subdivi-
sion into two categories: radiographic and nonradiographic, 
where the inflammatory changes are only visible in the MRI 
or completely absent [2]. Thereafter, this decision turned out 
to be crucial, since further research assessed the prevalence 
of nonradiographic axSpA in the whole axSpA cohort oscil-
lating between 20 and 80%, which is a substantial group, 
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previously omitted in the diagnostic process [3]. Thus, the 
mean diagnostic delay of axSpA decreased from approxi-
mately 7 to 2 years [4], which has also led to speeding up 
the introduction of proper therapy, before the occurrence of 
disabling structural changes in the SIJs and spine.
As the presence of active axSpA significantly diminishes 
patient’s health-related quality of life [5], it is vital to gain 
control over the disease as soon as possible and decrease the 
diagnostic delay to the greatest extent. This is the reason why 
there is still the need to search for techniques that increase 
the diagnostic accuracy of the axSpA in the early stage. One 
of the possible techniques is multiparametric MRI, which, 
apart from standard sequences, consists of methods such as 
diffusion-weighted imaging (DWI) and dynamic contrast-
enhanced (DCE) perfusion imaging. Nonetheless, the con-
sensus regarding its use in the diagnostics of axSpA has 
not been reached yet [6], due to the limited evidence and 
contradictory results of previous research [7–10].
The aim of the study was to assess the diagnostic perfor-
mance of the visual assessment of DWI sequence with ADC 
maps and DCE sequence in the detection of active sacroili-
itis in the course of axSpA, in comparison to the standard 
STIR sequence. A secondary aim was to assess if the pres-
ence of other signs of acute sacroiliitis, not mentioned in 
ASAS criteria, could aid the diagnosis of axSpA.
Materials and methods
The study obtained approval from the Institutional Bioethics 
Committee (No. of approval: 1072.6120.16.2019, date of 
approval: 31st January 2019).
Study population
We included into the retrospective study 49 patients who 
undergone multiparametric MRI of the SIJs due to the clini-
cal suspicion of axSpA. All examinations were performed 
between January 2017 and August 2018. The inclusion 
criterium was the clinical suspicion of sacroiliitis in the 
course of axSpA [11]. The exclusion criteria were: age < 18 
or > 45 years [11], the lack of clinical data about the rea-
son of referral, patients with a history of sacroiliac region 
trauma or neoplasm. The mean age of qualified patients 
was 28.9 ± 8.5 years (range 18–43 years), the percentage of 
females was 63.3% (n = 31) and males 36.7% (n = 18).
Examination protocol
All examinations were performed in 3.0 T MRI scanner 
(Achieva, Philips Healthcare, Amsterdam, Netherlands) with 
the use of 8 channel phased-array XL-torso body matrix coil. 
Both SIJs were imaged simultaneously from the anterior to 
the posterior border in the coronal oblique plane, parallel to 
the long axis of the sacral bone.
Detailed imaging parameters were:
• Coronal oblique T1-weighted turbo spin echo (TSE) 
sequence (TR 500 ms, TE 14 ms, flip angle 90, NEX 
1, slice thickness 3  mm, matrix 560 × 560, FOV 
240 × 240 × 71, scan time 3.02 min)
• Coronal oblique short tau inversion recovery (STIR) 
TSE sequence (TR 5239 ms, TE 30 ms, inversion time 
190 ms, flip angle 90, NEX 2, slice thickness 3 mm, 
matrix × 400 × 400, FOV 240 × 240 × 71, scan time 
2.15 min)
• Coronal oblique diffusion-weighted imaging (DWI)—
multitransmit single shot echo-planar (EPI) diffusion-
weighted imaging with multiple diffusion gradient b 
values of 0 and 800 s/mm2 (TR 3837 ms, TE 58 ms, flip 
angle 90, NEX 6, slice thickness 3 mm, matrix 192 × 192, 
FOV 350 × 292 × 132, scan time 2.45 min)
• Coronal oblique dynamic contrast-enhanced (DCE) 
sequence with fat saturation (e-THRIVE), acquired 34 
times (TR 3.4 ms, TE 1.7 ms, flip angle 10, slice thick-
ness 6 mm, matrix 176 × 176, FOV 240 × 250 × 71, scan 
time—4.30 min). Simultaneously with the launch of the 
acquisition, intravenous contrast agent gadobutrolum was 
administered (Gadovist, Bayer, Germany) at a dose of 
0.1 mmol/kg of body weight at a flow rate of 2.5 ml/s.
ADC maps were automatically created by the MR system. 
In several cases of the clinical doubts, ADC maps were cre-
ated manually.
Image interpretation
MR images were retrospectively assessed in random order 
by two independent observers, aware of the clinical suspi-
cion of axSpA, blinded to patients’ identities and clinical 
findings. In every patient, such sequences were individu-
ally evaluated: STIR combined with T1-weighted sequence 
(structural joint assessment), DWI sequence with b = 0 and 
800 with ADC map and DCE sequence. To standardize the 
visual assessment of these sequences, we used the SPARCC 
(Spondyloarthritis Research Consortium of Canada) score, 
with slight modifications (without the evaluation of depth 
and intensity of the inflammatory lesions) [12]. In every 
sequence, eight sections, with the longest visible part of the 
SIJ articular surface (> 1 cm), were chosen. On every sec-
tion, each SIJ was divided into four quadrants (upper iliac, 
upper sacral, lower iliac, lower sacral), what finally made the 
number of 64 quadrants evaluated in every sequence. Each 
quadrant was separately analysed for the presence of bone 
marrow oedema/osteitis related to the inflammatory sacro-
iliitis—the presence of typical subchondral bone marrow 
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oedema lesion [13] (STIR) or restricted diffusion (DWI, 
ADC) or contrast enhancement (DCE) was marked as 1, 
and the lack of these signs as 0. Moreover, every SIJ was 
assessed in STIR sequence for the presence of other signs 
of acute inflammatory sacroiliitis—enthesitis, capsulitis, and 
synovitis.
Clinical characteristics
The referral of every patient was studied for symptoms and 
test results, which were the reason for axSpA clinical sus-
picion—back pain, family history of SpA, peripheral joint 
arthritis, HLA-B27 haplotype, psoriasis, inflammatory 
bowel diseases, enthesitis, uveitis.
axSpA ASAS classification criteria
If the active inflammatory lesion according to ASAS cri-
teria [13] was identified in at least one joint of the particu-
lar patient in the STIR sequence, a patient was qualified to 
the group with ASAS positive sacroiliitis. If the particular 
patient belonged to an ASAS-positive sacroiliitis group and 
additionally had at least one typical axSpA feature, accord-
ing to ASAS criteria [2], in the next step, this patient was 
included into ASAS axSpA imaging arm positive group. As 
only patients suspected of axSpA were included into our 
study, there was not any patient fulfilling the clinical arm 
of ASAS criteria.
Statistical analysis
Statistical analysis was performed with the use of IBM 
SPSS Statistics for Windows, version 25.0. The normal-
ity of the data was checked using the Shapiro–Wilk test. 
The difference in age between groups was analysed using 
the Mann–Whitney U test. The correlation between two 
unpaired nominal variables was evaluated using Fisher’s 
exact test or Chi squared test. The results of bone mar-
row oedema/osteitis assessment from the DWI sequence 
with ADC map and DCE sequence were compared with 
the results from STIR sequence (which were treated as the 
reference) to calculate the accuracy, sensitivity, specific-
ity, positive (PPV) and negative (NPV) predictive values, 
for each observer separately. Inter-observer agreement was 
evaluated with the use of Cohen’s κ coefficient, the inter-
pretation was: κ < 0—poor agreement, 0 ≤ κ < 0.2—slight 
agreement, 0.2 ≤ κ < 0.4—fair agreement, 0.4 ≤ κ < 0.6—
moderate agreement, 0.6 ≤ κ < 0.8—substantial agreement 
and 0.8 ≤ κ < 1—almost perfect agreement. p values < 0.05 
were considered as statistically significant.
Results
Characteristics of the group
In general, 46.9% (n = 23) of the study group fulfilled the 
imaging arm of ASAS axSpA criteria. Mean SPARCC 
score of patients from the ASAS axSpA imaging arm posi-
tive group was 15.7 ± 15.9 (range 2–48). There was not any 
statistically significant difference in age (p = 0.195) and gen-
der (p = 0.130) between groups fulfilling the imaging arm of 
ASAS axSpA criteria and the group without the diagnosis 
of axSpA.
Detailed information regarding the characteristics of the 
group is shown in Table 1.
Diagnostic performance of DWI/ADC and DCE 
sequence vs. STIR sequence
The performance of the visual assessment of DWI sequence 
combined with ADC map and DCE sequence was com-
pared to the STIR sequence with regard to the detection of 
active sacroiliitis fulfilling ASAS criteria for axSpA. DWI 
Table 1  Clinical profile of 
patients included in the study
SD standard deviation
Parameter Patients fulfilling imaging 




Mean age (mean ± SD) 27.4 ± 8.8 30.4 ± 8.1 28.9 ± 8.5 years
Males 47.8% (n = 11) 26.9% (n = 7) 36.7% (n = 18)
ASAS axSpA imaging arm positive 100.0% (n = 23) 0.0% (n = 0) 46.9% (n = 23)
Back pain 82.6% (n = 19) 88.5% (n = 23) 85.7% (n = 42)
Peripheral arthritis 52.2% (n = 12) 19.2% (n = 5) 34.7% (n = 17)
Family history of SpA 17.4% (n = 4) 34.6% (n = 9) 26.5% (n = 13)
HLA-B27 haplotype 30.4% (n = 7) 7.7% (n = 2) 18.4% (n = 9)
Psoriasis 21.7% (n = 5) 11.5% (n = 3) 16.3% (n = 8)
Uveitis 0.0% (n = 0) 3.8% (n = 1) 5.3% (n = 1)
Inflammatory bowel disease 4.3% (n = 1) 0.0% (n = 0) 5.3% (n = 1)
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sequence with ADC map had slightly higher sensitivity and 
markedly lower specificity than DCE sequence in the detec-
tion of active sacroiliitis. Accuracy and PPV were slightly 
higher for DCE sequence than for DWI sequence with ADC, 
contrary to the NPV, which was higher for DWI sequence 
with ADC map.
A comprehensive summary of accuracy, sensitivity, 
specificity, PPV and NPV values for DWI sequence with 
ADC map and DCE sequence for both observers is shown 
in Table 2.
Inter‑observer agreement
The level of agreement was compared between both the 
observers. The highest inter-rater agreement was achieved 
for STIR sequence, which was almost perfect (κ = 0.888). 
The level of agreement was similar both for DWI sequence 
with ADC map (κ = 0.674) and DCE sequence (κ = 0.773), 
with a slight advantage of the DCE sequence.
Details concerning the inter-observer agreement of STIR, 
DWI sequence with ADC map and DCE sequence are pro-
vided in Table 3.
We also assessed the inter-observer agreement for 
SPARCC scoring and the agreement was almost perfect, 
at the same level as for STIR sequence (κ = 0.888), with a 
slightly narrower 95% confidence interval (CI 0.882–0.894).
Remaining active sacroiliitis symptoms vs. ASAS 
axSpA diagnosis
In the last step, the diagnostic performance of active sacro-
iliitis additional signs during the identification of patients 
fulfilling imaging arm of the ASAS axSpA classification cri-
teria was assessed. Signs of synovitis were present in 18.4% 
(n = 9) of all patients, capsulitis in 16.3% (n = 8) and enthesi-
tis in 10.2% (n = 5). Synovitis (34.8% with axSpA vs. 3.8% 
without; p = 0.008) and capsulitis (34.8% with axSpA vs. 
0.0% without; p = 0.001) were significantly more frequently 
present in patients with axSpA, in comparison to the cohort 
without axSpA. A similar correlation was not detected for 
the presence of enthesitis (17.4% with axSpA vs. 3.8% with-
out; p = 0.173). Although all these signs achieved high sen-
sitivity for the identification of patients with axSpA, but the 
specificity was very poor.
More information regarding the diagnostic performance 
of these signs is presented in Table 4.
Discussion
Our results show that the visual assessment of DWI sequence 
paired with ADC map has similar accuracy, sensitivity and 
PPV to DCE technique, which remained high for both these 
sequences. On the other hand, both these sequences have 
poor specificity (especially DWI) in comparison to the gold 
standard, which is the STIR sequence [1]. Thus, visual 
assessment of these sequences does not seem to be helpful 
in early detection of active sacroiliitis. This finding is con-
sistent with Boy et al.’s conclusions that the addition of the 
visual assessment of DWI and DCE sequences to the axSpA 
diagnostic path does not aid the diagnosis of sacroiliitis, both 
for less and more experienced radiologists [9]. The primary 
drawback of these two sequences, which could explain their 
poor effectiveness in visual assessment of the SIJs, may be 
their markedly lower contrast to noise ratios in compari-
son to the STIR sequence [14]. As a decreased contrast to 
noise ratio diminishes the clear definition of the lesion, the 
visual assessment of the SIJs in these sequences is hindered. 
Table 2  The summary 
regarding the measures of 
diagnostic performance for DWI 
sequence with ADC map and 
DCE sequence in comparison 
to STIR sequence for both 
observers
DWI with ADC map DCE
Observer 1 Observer 2 Mean Observer 1 Observer 2 Mean
Accuracy (%) 96.2 95.0 95.6 97.3 96.3 96.8
Sensitivity (%) 99.3 99.5 99.4 99.1 97.6 98.4
Specificity (%) 60.2 47.7 54.0 76.3 82.7 79.5
PPV (%) 96.6 95.3 96.0 97.9 98.3 98.1
NPV (%) 88.8 90.1 89.5 88.4 76.4 82.4
Table 3  Inter-observer agreement of various sequences used in our 
study
Sequence κ value 95% confidence interval Level of agreement
STIR 0.888 0.856–0.918 Almost perfect
DWI + ADC 0.674 0.604–0.733 Substantial
DCE 0.773 0.731–0.815 Substantial
Table 4  The diagnostic performance of synovitis, capsulitis and 
enthesitis in the identification of patients with axSpA
Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Synovitis 96.2 34.8 62.5 88.9
Capsulitis 100.0 34.8 63.4 100.0
Enthesitis 96.2 17.4 56.8 80.0
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Noticeably, the decreased specificity of DWI sequence in 
comparison to DCE sequence may be also caused by par-
ticular susceptibility of this sequence to artefacts, such as 
“T2 shine through”, “T2 black out”, ghosting, blurring and 
distortions [15]. Obviously, the additional analysis of ADC 
maps, which we performed, helps to discriminate between 
actual lesions and some artefacts, but generally these maps 
are hard to interpret [16], especially in the case of small 
lesions.
In all sequences, the SIJs were assessed in the systematic 
way, with the use of a method based on the SPARCC score 
[12], but without the evaluation of depth and intensity of 
the lesion and while using a set number of assessed slices. 
It enabled us to ensure that the visual assessment was suf-
ficiently thorough, and observers identified and considered 
the same changes as pathologic in particular examination. 
Thus, it was possible to credibly evaluate the inter-observer 
agreement. The highest value of this parameter was achieved 
by the STIR sequence, which confirms that its visual assess-
ment is notably easier and more precise than the sequences 
of multiparametric MRI. The agreement for DWI sequence 
with ADC maps and DCE sequence was acceptable and at 
a similar level, moderately with the advantage of the DCE 
sequence. In spite of the higher inter-observer agreement of 
DCE sequence and slightly better overall diagnostic perfor-
mance in the diagnostics of active sacroiliitis, it still remains 
in a lost position in comparison to DWI sequence. The first 
reason is that it requires gadolinium-based contrast media 
administration, which may cause adverse effects and should 
not be overused due to the risk of gadolinium depositions 
in the brain and bones [17]. Moreover, this is a sequence of 
long acquisition time in comparison to the basic sequences 
(twice longer acquisition time than STIR sequence) and DWI 
sequence. In contrast, DWI sequence does not require gado-
linium contrast media administration and its acquisition time 
is similar to the STIR sequence. Taking into consideration 
all above-mentioned aspects, neither the visual assessment 
of DWI sequence, nor DCE sequence seem to be promising 
for the early detection of active sacroiliitis in MRI.
An additional parameter, that we assessed in this study, 
was the presence of concomitant symptoms of active sacro-
iliitis such as synovitis, capsulitis, and enthesitis. Overall, 
they were not very prevalent in the axSpA-positive group 
(synovitis: 34.8% of patients with axSpA, capsulitis 34.8% 
and enthesitis 17.4%), but they exhibited high sensitivity 
for axSpA positive patient identification. Nonetheless, their 
specificity was extremely low and enthesitis was not even 
statistically significantly more prevalent in the group with 
axSpA, in comparison to axSpA-negative patients. This sup-
ports the statement of Lambert et al. that these changes are 
not sufficient to identify the active sacroiliitis, without coex-
isting, highly suggestive of SpA, bone marrow oedema [13]. 
They could only give a hint about the probable diagnosis if 
bone marrow oedema is present, but their overall signifi-
cance is low.
Of course, we cannot omit the fact that several previ-
ous authors reported the high relevance of quantitative 
assessment of ADC value in the differentiation of axSpA 
and non-inflammatory lesions [7, 18–23] as well as in the 
monitoring of axSpA treatment [8, 24]. The mean ADC was 
higher in patients with an active axSpA in comparison to 
patients with low back pain of mechanical origin [20, 21], 
Modic 1 changes in spine [22, 23] and healthy individu-
als [18–20]. Furthermore, according to previous research, 
ADC value measured within the bone lesions correlates with 
C-related protein level [7], disease activity (BASDAI—Bath 
Ankylosing Spondylitis Disease Activity Index), functional 
impairment (BASFI—Bath Ankylosing Spondylitis Func-
tional Index) and patient global assessment (BASGI—Bath 
Ankylosing Spondylitis Global Index) scores [25]. These 
results seem to be promising and further research is vital. 
First of all, a reliable methodology of ADC value measure-
ment should be developed and uniformed between the future 
studies. Currently, some authors perform a direct measure-
ment of ADC value [7, 18, 20, 21], while the others calcu-
late the relative ADC value [10, 19], referring it to an unaf-
fected bone, for instance, in the midline of the sacral bone 
[10]. Additionally, in some reports, there is a comparison 
between ADC value within the inflammatory lesions and 
to the one measured within the unaffected bone [7, 10, 18, 
20, 21], while in the others, mean ADC value from regions 
unaffected by bone marrow oedema or structural changes is 
globally assessed and compared between the sides and the 
groups with and without axSpA [19]. These discrepancies 
hinder the reliable comparison of previous authors’ results. 
Moreover, as the values of ADC significantly differ accord-
ing to age and sex, it is advisable to use a rather relative 
ADC value [16]. We should also be especially careful with 
ADC value measurement in younger cohorts, as ADC value 
in skeletally immature patients could overlap with the values 
reported for the active sacroiliitis [26]. Another important 
issue, that has not been covered yet, is the ADC value cutoff 
points for discrimination between healthy individuals and 
patients with active axSpA. Nonetheless, apart from all these 
diagnostic pitfalls of DWI sequence, there are still doubts 
if the measurement of ADC value, and in consequence, the 
addition of DWI sequence to the axSpA diagnostic algo-
rithm, is really beneficial. First, as Lambert et al. emphasize, 
numerical data could be obtained from any MRI sequence, 
not only from more advanced sequences of multiparamet-
ric MRI [16]. A good example of a validated and feasible 
method is a semi-quantitative assessment of active inflam-
matory lesions with the use of SPARCC score [12]. Our 
results regarding an almost perfect level of inter-observer 
agreement obtained for SPARCC scoring further confirmed 
its reliability. To facilitate the process of SIJ evaluation even 
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more, CaRE (Canadian Research and Education) Arthritis 
Organization is providing a simple, schematic SPARCC 
scoring interface, available on their website [16]. Second, 
the measurement of ADC values inside very small lesions 
could be highly time consuming and inexact. Third, the 
reproducibility of ADC measurement is questionable and its 
values can even vary while using the same MR system [15]. 
Hence, future research should focus on the standardization 
of ADC value measurement methods and their validation, 
instead of searching solely for its spectacular correlations 
with the disease.
This study also has some limitations, namely its retro-
spective design and small study group. The only lesion 
in our study, whose visibility was evaluated between the 
sequences, was bone marrow oedema, which is not pathog-
nomonic for axSpA and might be present in up to 23% of 
patients with non-specific back pain and in approximately 
7% of healthy volunteers. In consequence, the MRI examina-
tion result should be always correlated with clinical symp-
toms and laboratory results of particular patients [27]. Fur-
thermore, we did not assess any quantitative data deriving 
from analysed sequences, yet it is within our future research 
agenda.
Conclusions
The visual assessment of DWI sequence with ADC maps 
and DCE sequence is characterised by high accuracy and 
sensitivity of bone marrow oedema/osteitis detection, but 
the specificity of these sequences is poor, especially for 
the DWI sequence with ADC maps. Moreover, the inter-
observer agreement of these two sequences is lower than 
the one calculated for the STIR sequence. Hence, the visual 
assessment of DWI and DCE sequences is not beneficial 
in the early diagnosis of active sacroiliitis in the course of 
axSpA. As well, the presence of additional signs of active 
sacroiliitis (synovitis, capsulitis, and enthesitis) does not aid 
the diagnosis of the axSpA.
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